13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001902506
Total reported value
$427.8M
$427.8M
129 檔
45.9%
During the Q4 2025 filing period, Straight Path Wealth Management (CIK: 0001902506) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $427.8M across 129 reported positions.
In Q4 2025, Straight Path Wealth Management displayed an active expansion posture, initiating 13 new positions and adding to 67 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DFAC | Dimensional US Core Equity 2 | ETF-Other | 18.17% | +0.63% | +5.53% | |
| 2 | TSLA | Tesla Inc | Stock-Consumer Disc | 14.33% | -0.12% | -4.44% | |
| 3 | DFIC | Dimensional International Co | ETF-Other | 9.24% | -0.65% | +4.68% | |
| 4 | DFGP | Dimensional Glbl Core Pl Fix | ETF-Other | 6.35% | -0.46% | +6.06% | |
| 5 | MTUM | Ishares Msci USA Momentum Fa | ETF-Other | 4.87% | +0.88% | +3.47% | |
| 6 | DFEM | Dimensional Emrg Mrkt Core | ETF-Other | 3.92% | +0.04% | +4.07% | |
| 7 | IMTM | Ishares Msci Intl Momentum F | ETF-Other | 3.66% | -0.06% | +3.67% | |
| 8 | BSCS | Invesco Bulletshares 2028 Cb | ETF-Other | 2.84% | -0.28% | +6.90% | |
| 9 | BSCT | Invesco Bulletshares 2029 Cb | ETF-Other | 2.77% | -0.32% | +149.28% | |
| 10 | BSCR | Invesco Bulletshares 2027 Cb | ETF-Other | 2.76% | -0.29% | +4.87% | |
| 11 | BSCQ | Invesco Bulletshares 2026 Cb | ETF-Other | 2.60% | -0.23% | +1.92% | |
| 12 | DFAR | Dimensional US Real Est ETF | ETF-Other | 1.78% | -0.01% | +9.14% | |
| 13 | STIP | Ishares 0-5 Year Tips Bond E | ETF-Other | 1.66% | -0.15% | +4.64% | |
| 14 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 1.20% | +0.17% | +0.14% | |
| 15 | BSCU | Invesco Bulletshares 2030 Cb | ETF-Other | 1.18% | -0.15% | +9.62% | |
| 16 | BSCV | Invesco Bulletshares 2031 Cb | ETF-Other | 1.12% | -0.15% | +9.90% | |
| 17 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 1.04% | -0.20% | -29.01% | |
| 18 | BSCW | Invesco Bulletshares 2032 Cb | ETF-Other | 0.89% | -0.11% | +192.16% | |
| 19 | PJUL | Innovator U.s. Equity Power | ETF-Other | 0.87% | -0.03% | +0.41% | |
| 20 | IBHH | Ishares Ibonds 2028 Tm Hy In | ETF-Other | 0.77% | -0.05% | +8.94% | |
| 21 | IBHF | Ishares Ibond 2026 Hy & Inc | ETF-Other | 0.73% | -0.06% | +2.44% | |
| 22 | IBHG | Ishares Ibonds 2027 Hy Inc | ETF-Other | 0.70% | -0.05% | +8.54% | |
| 23 | IBHI | Ishares Ibonds 2029 Tm Hy In | ETF-Other | 0.70% | -0.02% | +42.17% | |
| 24 | BND | Vanguard Total Bond Market | ETF-Other | 0.60% | +0.51% | +1.30% | |
| 25 | IBHJ | Ishrs Ibds 2030 Hy & Inc ETF | ETF-Other | 0.51% | -0.06% | +10.66% | |
| 26 | IBHK | Isharesibond2031highyldinc | ETF-Other | 0.43% | -0.05% | +17.90% | |
| 27 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 0.42% | — | -37.50% | |
| 28 | PFE | Pfizer Inc | Stock-Healthcare | 0.36% | -0.11% | -43.33% | |
| 29 | RKLB | Rocket Lab CORP | Stock-Industrials | 0.34% | — | -56.87% | |
| 30 | PAPR | Innovator U.s. Equity Power | ETF-Other | 0.32% | -0.02% | +1.53% | |
| 31 | IJUL | Innovator International Deve | ETF-Other | 0.31% | -0.02% | +1.11% | |
| 32 | ALAB | Astera Labs Inc | Stock-Tech | 0.30% | +0.53% | -49.44% | |
| 33 | HDV | Ishares Core High Dividend E | ETF-Other | 0.30% | +0.07% | +1.03% | |
| 34 | IBHL | Ishares Ibonds 2032 Hy Inc | ETF-Other | 0.30% | -0.03% | +280.00% | |
| 35 | HOOD | Robinhood Markets Inc - A | Stock-Financials | 0.30% | +0.04% | +4.30% | |
| 36 | CRDO | Credo Technology Group Holding Ltd | Stock-Tech | 0.28% | +0.27% | -80.27% | |
| 37 | AAPL | Apple Inc | Stock-Tech | 0.27% | — | +3.64% | |
| 38 | ABBV | Abbvie Inc | Stock-Healthcare | 0.27% | — | — | |
| 39 | IBTH | Ishares Ibonds Dec 2027 Term | ETF-Other | 0.26% | -0.03% | +68.06% | |
| 40 | BOXX | Alpha Architect 1-3 Mnth Box | ETF-Other | 0.26% | -0.03% | +33.36% | |
| 41 | PSEP | Innovator U.s. Equity Power | ETF-Other | 0.25% | -0.02% | — | |
| 42 | PHYS | Sprott Physical Gold Trust | Stock-Other | 0.25% | -0.10% | -4.25% | |
| 43 | IBTG | Ishares Ibonds Dec 2026 Term | ETF-Other | 0.25% | -0.04% | +46.36% | |
| 44 | INFL | Horizon Kinetics Infl Benef | ETF-Other | 0.22% | -0.04% | +8.48% | |
| 45 | IBDR | Ishares Ibonds Dec 2026 Term | ETF-Other | 0.22% | +0.01% | +21.20% | |
| 46 | ARKK | Ark Innovation ETF | ETF-Other | 0.22% | +0.01% | -9.17% | |
| 47 | BNDX | Vanguard Total Intl Bond ETF | ETF-Other | 0.21% | +0.19% | +2.65% | |
| 48 | PMAR | Innovator U.s. Equity Power | ETF-Other | 0.21% | -0.02% | -0.13% | |
| 49 | KJUL | Innovator U.s. Small Cap Pow | ETF-Small Cap | 0.20% | -0.01% | +0.48% | |
| 50 | IBTI | Ishares Ibonds Dec 2028 Term | ETF-Other | 0.19% | -0.02% | +30.35% |
According to official SEC Form 13F filings, Straight Path Wealth Management reported a total U.S. public equity portfolio value of $427.8M across 129 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including DFAC, TSLA, DFIC) accounted for 45.9% of total reported equity market value during Q4 2025.
Top New Position Initiated
IBTJ
市值: $620.0K
Top Position Liquidated / Trimmed
BSCP
前期市值: $6.8M
During Q4 2025, Straight Path Wealth Management's top holdings by market value included DFAC (18.2%)、TSLA (14.3%)、DFIC (9.2%). The largest single position, DFAC, represented 18.2% of total portfolio value.
In Q4 2025, Straight Path Wealth Management made 121 total portfolio adjustments, initiating 13 new buys, adding to 67 positions, trimming 29 holdings, and fully liquidating 12 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.